Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent. A critical turning point in combating this virus was the development of a preventative vaccine composed of the HBV surface (envelope) prote...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2020-01-01
|
| Sarja: | Viruses |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1999-4915/12/2/126 |